Computational Structural Biology
Our research group is at the forefront of developing a new generation of computational tools that integrate physics, artificial intelligence, and computational biology to transform drug design. We focus on two primary goals: developing mathematically elegant deep learning architectures that incorporate physical principles to model macromolecular structure and function at the genome scale, and applying these approaches to design therapeutic molecules with precise biological properties. By explaining disease mechanisms at the molecular level, our work aims to accelerate the drug discovery process, reduce costs, and unlock new possibilities for targeting complex conditions, particularly difficult-to-treat cancers.
Directors
Faculty and Research Staff
Students
Staff
News
Oct. 15, 2025
Dima Kozakov, recently recruited to UT Austin’s Oden Institute and College of Natural Sciences, is leading a new research center focused on integrating AI and physics into drug discovery. His team aims to revolutionize cancer therapeutics by developing physics-aware AI models that accelerate personalized treatment design and translation into clinical impact.
News
Sept. 29, 2025
Charles Taylor and Dima Kozakov are recipients of major grants from the State of Texas. Taylor received the Governor’s University Research Initiative (GURI) grant, and Kozakov received a grant from the Cancer Prevention and Research Institute of Texas (CPRIT).